BOLLI, NICCOLO'
BOLLI, NICCOLO'
Dipartimento di Oncologia ed Emato-Oncologia
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers
2024 D. Ronchetti, V. Traini, I. Silvestris, G. Fabbiano, F. Passamonti, N. Bolli, E. Taiana
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma
2024 M. Resnati, S. Pennacchio, L. Viviani, T. Perini, M. Materozzi, U. Orfanelli, J. Bordini, R. Molteni, M. Nuvolone, M. Da Vià, F. Lazzaroni, N. Bolli, S. Cenci, E. Milan
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion
2024 B. Bassani, G. Simonetti, V. Cancila, A. Fiorino, M. Ciciarello, A. Piva, A.M. Khorasani, C. Chiodoni, D. Lecis, A. Gulino, E. Fonzi, L. Botti, P. Portararo, M. Costanza, M. Brambilla, G. Colombo, J. Schwaller, A. Tzankov, M. Ponzoni, F. Ciceri, N. Bolli, A. Curti, C. Tripodo, M.P. Colombo, S. Sangaletti
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
2024 M. Sciumè, F. Serpenti, R. Zanotti, P. Bonadonna, I. Tanasi, L. Crosera, C. Elena, F. Mannelli, F. Crupi, C. Papayannidis, C. Sartor, S. Soverini, M. Rondoni, C. Eller-Vainicher, V. Pravettoni, F. Rivolta, S. Alberti Violetti, G.A. Croci, A.C. Migliorini, N. Bolli, D. Giannarelli, F.I. Grifoni
Genomic Classification and Individualized Prognosis in Multiple Myeloma
2024 F. Maura, A.R. Rajanna, B. Ziccheddu, A.M. Poos, A. Derkach, K. Maclachlan, M. Durante, B. Diamond, M. Papadimitriou, F. Davies, E.M. Boyle, B. Walker, M. Hultcrantz, A. Silva, O. Hampton, J.K. Teer, E.M. Siegel, N. Bolli, G.H. Jackson, M. Kaiser, C. Pawlyn, G. Cook, D. Kazandjian, C. Stein, M. Chesi, L. Bergsagel, E.K. Mai, H. Goldschmidt, K.C. Weisel, R. Fenk, M.S. Raab, F. Van Rhee, S. Usmani, K.H. Shain, N. Weinhold, G. Morgan, O. Landgren
Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases
2024 D. Cattaneo, A. Marchetti, C. Bucelli, N. Galli, M. Lionetti, V. Bellani, U. Gianelli, F. Passamonti, N. Bolli, A. Iurlo
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease
2024 A. Marchetti, S. Pelusi, A. Marella, F. Malvestiti, A. Ricchiuti, L. Ronzoni, M. Lionetti, V. Moretti, E. Bugianesi, L. Miele, U. Vespasiani-Gentilucci, P. Dongiovanni, A. Federico, G. Soardo, R. D'Ambrosio, M.V. Mccain, H.L. Reeves, V. La Mura, D. Prati, N. Bolli, L. Valenti, S. Margarita, C. Bianco, A. Cherubini, R. Carpani, V. Borroni, V. Vaira, C. Rosso, A. Liguori, F. Tavaglione, G. Pennisi, S. Petta, F.P. Russo
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification
2024 V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, G. Fabbiano, V. Traini, K. Todoerti, S. Erratico, A. Ciarrocchi, V. Fragliasso, D. Giannandrea, F. Tumiatti, R. Chiaramonte, Y. Torrente, P. Finelli, E. Morelli, N.C. Munshi, N. Bolli, A. Neri, E. Taìana
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma
2024 F. Bagnoli, G. Pini, B. Ziccheddu, A. Bonometti, S. Alberti-Violetti, L. Venegoni, G. Isimbaldi, M.C. Da Vià, A. Ferrari, L. Baldini, A. Neri, F. Onida, N. Bolli, E. Berti
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis
2024 F. Lazzaroni, A. Matera, A. Marella, A. Maeda, G. Castellano, A. Marchetti, S. Fabris, S. Pioggia, I. Silvestris, D. Ronchetti, S. Lonati, G. Fabbiano, V. Traini, E. Taiana, L. Porretti, F. Colombo, C. De Magistris, M. Scopetti, M. Barbieri, L. Pettine, F. Torricelli, A. Neri, F. Passamonti, M. Lionetti, M.C. Da Vià, N. Bolli
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024 B. Ziccheddu, C. Giannotta, M. D'Agostino, G. Bertuglia, E. Saraci, S. Oliva, E. Genuardi, M. Papadimitriou, B. Diamond, P. Corradini, D. Coffey, O. Landgren, N. Bolli, B. Bruno, M. Boccadoro, M. Massaia, F. Maura, A. Larocca
Circulating biomarkers in familial cerebral cavernous malformation
2024 F. Lazzaroni, J.M.T.A. Meessen, Y. Sun, S. Lanfranconi, E. Scola, Q.G. D'Alessandris, L. Tassi, M.R. Carriero, M. Castori, S. Marino, A. Blanda, E.B. Nicolis, D. Novelli, R. Calabrese, N.M. Agnelli, B. Bottazzi, R. Leone, S. Mazzola, S. Besana, C. Catozzi, L. Nezi, M.G. Lampugnani, M. Malinverno, N. Grdseloff, C.J. Rödel, B. Rezai Jahromi, N. Bolli, F. Passamonti, P.U. Magnusson, S. Abdelilah-Seyfried, E. Dejana, R. Latini
Clonal Hematopoiesis of Indeterminate Potential in Patients with Immunoglobulin Light Chain AL Amyloidosis
2024 P. Lopedote, B. Evans, A. Marchetti, T. Chen, M. Moscvin, S. Boullt, N. Bolli, G. Bianchi
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
2023 E. Sauta, M. Robin, M. Bersanelli, E. Travaglino, M. Meggendorfer, L. Zhao, J.C. Caballero Berrocal, C. Sala, G. Maggioni, M. Bernardi, C. Di Grazia, L. Vago, G. Rivoli, L. Borin, S. D'Amico, C.A. Tentori, M. Ubezio, A. Campagna, A. Russo, D. Mannina, L. Lanino, P. Chiusolo, L. Giaccone, M.T. Voso, M. Riva, E.N. Oliva, M. Zampini, E. Riva, O. Nibourel, M. Bicchieri, N. Bolli, A. Rambaldi, F. Passamonti, V. Savevski, A. Santoro, U. Germing, S. Kordasti, V. Santini, M. Diez-Campelo, G. Sanz, F. Sole, W. Kern, U. Platzbecker, L. Ades, P. Fenaux, T. Haferlach, G. Castellani, M.G. Della Porta
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
2023 B. Diamond, B. Ziccheddu, K. Maclachlan, J. Taylor, E. Boyle, J.A. Ossa, J. Jahn, M. Affer, T.M. Totiger, D. Coffey, N. Chandhok, J. Watts, L. Cimmino, S.X. Lu, N. Bolli, K. Bolton, H. Landau, J.H. Park, K. Ganesh, A. Mcpherson, M.A. Sekeres, A. Lesokhin, D.J. Chung, Y. Zhang, C. Ho, M. Roshal, J. Tyner, S. Nimer, E. Papaemmanuil, S. Usmani, G. Morgan, O. Landgren, F. Maura
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma
2023 N. Platonova, E. Lazzari, M. Colombo, M. Falleni, D. Tosi, D. Giannandrea, V. Citro, L. Casati, D. Ronchetti, N. Bolli, A. Neri, F. Torricelli, L.A. Crews, C.H.M. Jamieson, R. Chiaramonte
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma
2023 L. Haertle, S. Barrio, U. Munawar, S. Han, X. Zhou, M. Simicek, C. Vogt, M. Truger, R.A. Fernandez, M. Steinhardt, J. Weingart, R. Snaurova, S. Nerreter, E. Teufel, A. Garitano-Trojaola, M. Da Via, Y. Ruiz-Heredia, A. Rosenwald, N. Bolli, R. Hajek, P. Raab, M.S. Raab, N. Weinhold, C. Haferlach, T. Haaf, J. Martinez-Lopez, H. Einsele, L. Rasche, K.M. Kortüm
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy
2023 M. Moscvin, C.I. Liacos, T. Chen, F. Theodorakakou, D. Fotiou, S. Hossain, S. Rowell, H. Leblebjian, E. Regan, P. Czarnecki, F. Bagnoli, N. Bolli, P. Richardson, H.G. Rennke, M.A. Dimopoulos, E. Kastritis, G. Bianchi
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
2023 B. Ziccheddu, C. Giannotta, M. D'Agostino, G. Bertuglia, E. Saraci, S. Oliva, E. Genuardi, M. Papadimitriou, B. Diamond, P. Corradini, D. Coffey, O. Landgren, N. Bolli, B. Bruno, M. Boccadoro, M. Massaia, F. Maura, A. Larocca
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort
2023 D. Cattaneo, C. Bucelli, A. Marchetti, M. Lionetti, E. Fermo, V. Bellani, C. De Magistris, A. Maeda, A. Marella, M. Primignani, D. Consonni, U. Gianelli, A. Neri, L. Baldini, N. Bolli, A. Iurlo